查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088829

外泌體研究市場：2026-2032年全球市場預測（按產品、分離方法、檢體來源、適應症、應用和最終用戶分類）

Exosome Research Market by Offering, Method of Isolation, Sample Source, Indication, Applications, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，外泌體研究市場將成長至 4.7974 億美元，複合年成長率為 13.11%。

主要市場統計數據
基準年 2025 2.0243億美元
預計年份：2026年 2.2828億美元
預測年份 2032 4.7974億美元
複合年成長率 (%) 13.11%

外泌體研究導論

外泌體研究正從細胞外囊泡生物學的探索階段邁向診斷、藥物傳遞和再生醫學等轉化應用領域。外泌體是細胞釋放的奈米級細胞外囊泡，其在細胞間通訊、疾病訊號傳導、免疫調節和生物標記運輸中的作用正被廣泛研究。外泌體包含蛋白質、脂質、DNA片段、mRNA、 微型RNA和其他非編碼RNA等多種成分，在液態生物檢體、腫瘤學、神經病學、心血管代謝疾病、感染疾病和精準醫療等領域發揮著至關重要的作用。

外泌體研究前景的變革性變化

外泌體研究正在經歷一場變革，從基礎研究轉向旨在產生證據的轉化平台。研究人員正優先考慮可重複的分離方法、標準化的報告、功效檢測以及具有臨床意義的生物標記的檢驗，以應對長期存在的挑戰，例如異質性、檢體處理和分析可比性。這種轉變至關重要，因為細胞外囊泡的組成會因細胞來源、疾病狀態、生物體液類型和純化流程的不同而有所差異。

人工智慧對外泌體研究的累積影響

人工智慧透過提升複雜細胞外囊泡資料集的訊號檢測能力，進一步增強了外泌體研究的價值。機器學習模型有助於對囊泡亞群進行分類，解讀蛋白質體學和轉錄組學特徵，檢測疾病相關模式，並整合來自液態生物檢體工作流程的多組體學數據。人工智慧驅動的影像分析和頻譜解讀進一步提升了奈米顆粒追蹤分析、流式細胞技術、電子顯微鏡、拉曼光譜和其他表徵技術的性能。

全球外泌體研究的主要區域趨勢

亞太地區正崛起為外泌體研究的領先中心，這得益於中國、日本、韓國、印度、澳洲和東南亞國協在生物醫學領域的大力投資。該地區受益於不斷擴展的基因組學基礎設施、活性化的癌症和慢性病研究以及政府主導的生物技術計畫。北美繼續保持其領先中心的地位，這得益於美國國立衛生研究院資助的細胞外囊泡科學、先進的臨床試驗網路、風險投資以及成熟的液態生物檢體、生技藥品生產和產學研合作生態系統。

關鍵小組對胞外體研究生態系的見解

東協正透過在新加坡、泰國、馬來西亞、印尼、越南和菲律賓等地擴建生物醫學中心，加強其在胞外囊泡研究領域的作用，預計將在癌症診斷、再生醫學和感染疾病研究領域迎來發展機會。海灣合作理事會（GCC）在基因組學、專科醫院和研究型大學方面的投資支持下，正將胞外囊泡相關創新納入其更廣泛的精準醫療和醫療保健現代化策略。歐盟則透過共同資助、建立臨床研究網路以及協調先進療法和體外診斷的監管要求，為細胞外囊泡科學提供合作環境。

影響外泌體研究的主要國家趨勢

美國透過國立衛生研究院 (NIH) 支持的科學研究、美國食品藥物管理局 (FDA) 監管的臨床開發、創業投資支持的食品藥物管理局以及活躍的大學衍生企業，引領著外泌體研究的商業化進程。同時，加拿大透過細胞療法、腫瘤學和細胞外囊泡研究網路做出貢獻。墨西哥和巴西正在拓展其在臨床研究、腫瘤學和學術生命科學領域的能力，其中巴西在拉丁美洲的研究領域處於領先地位。在歐洲，英國、德國、法國、義大利和西班牙積極進行細胞外囊泡生物學、診斷和轉化醫學研究，而俄羅斯則對奈米醫學、分子生物學和再生醫學應用保持著濃厚的研究興趣。

為行業領導者提供的實用建議

產業領導者應優先考慮標準化而非規模化。外泌體研究計畫需要檢驗的分離流程、正交的表徵方法、批次間可比性以及符合國際細胞外囊泡報告指南的清晰文件。開發外泌體診斷方法的機構應儘早投資於監管策略，以進行臨床檢驗、建立生物體液特異性參考範圍、進行分析前控制以及完成體外診斷醫療設備的核准流程。

調查方法

本執行摘要遵循實證二級研究原則，包括對經同行評審的細胞外囊泡文獻、監管指令、臨床試驗趨勢、國際指南以及權威科學和衛生機構發布的機構資訊的回顧。它著重於標準化、轉化驗證、人工智慧驅動的分析和區域研究能力等檢驗的主題，而非未經證實的市場宣傳。

結論

外泌體研究已進入關鍵階段，科學潛力必須與可重複性、監管規範和臨床驗證相輔相成。液態生物檢體、多組體學物標記發現、工程化外泌體遞送、再生醫學和人工智慧驅動的細胞外囊泡分析等領域正湧現出巨大的機會。未來的進展取決於統一的標準、透明的檢驗和可擴展的生產。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 外泌體研究市場：依產品/服務分類

  • 試劑盒和試劑
    • 分離純化試劑盒
    • 標識和追蹤套件
    • 表徵和定量分析
    • 樣品製備及細胞培養試劑
  • 裝置
    • 電子顯微鏡
    • 流式細胞儀
    • 奈米顆粒追蹤分析（NTA）
  • 服務
    • 分析服務
    • 分離服務
    • 諮詢服務

第8章 外泌體研究市場：依分離法分類

  • 親和性和捕獲
  • 利用微流體技術進行分離
  • 降水法
  • 尺寸排阻層析法（SEC）
  • 超速離心

第9章：外泌體研究市場：依樣本來源分類

  • 血
  • 尿
  • 唾液
  • 組織起源

第10章：外泌體研究市場：依適應症分類

  • 循環系統
  • 神經病學
    • 阿茲海默症
    • 多發性硬化症
  • 腫瘤學
    • 乳癌
    • 結腸癌
    • 肺癌
    • 攝護腺癌

第11章 外泌體研究市場：依應用領域分類

  • 治療用途
  • 診斷和生物標記發現
  • 研究與開發

第12章 外泌體研究市場：依最終使用者分類

  • 學術研究機構
  • 受託研究機構
  • 醫院和診所
  • 製藥和生物技術公司

第13章：外泌體研究市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：外泌體研究市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：外泌體研究市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Bio-Techne Corporation
  • Abcam PLC by Danaher Corporation
  • Lonza Group AG
  • System Biosciences, LLC by CellBio Scientific
  • Miltenyi Biotec GmbH
  • Takara Bio Inc.
  • Evox Therapeutics Ltd.
  • Capricor Therapeutics, Inc.
  • ILIAS Biologics, Inc.
  • ExoCoBio Inc.
  • Aethlon Medical, Inc.
  • Coya Therapeutics
  • Alpha Analytical Laboratories by Pace Analytical Services
  • BioCat GmbH by AddLife AB
  • BioIVT, LLC
  • Creative Biolabs
  • Cusabio Technology LLC
  • Diagenode Inc. by Hologic, Inc.
  • Europa Biosite Group
  • Fujifilm Holdings Corporation
  • HiSS Diagnostics GmbH
  • MBL International Corporation
  • NanoSomiX, Inc.
  • nRichDX Inc.
  • Nx Pharmagen Inc.
  • Rion, Inc.
  • RoosterBio, Inc.
  • Spectris plc
Product Code: MRR-AD36CD897B3A

The Exosome Research Market is projected to grow by USD 479.74 million at a CAGR of 13.11% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 202.43 million
Estimated Year [2026] USD 228.28 million
Forecast Year [2032] USD 479.74 million
CAGR (%) 13.11%

Executive Introduction to Exosome Research

Exosome research is moving from exploratory extracellular vesicle biology toward translational applications in diagnostics, drug delivery, and regenerative medicine. Exosomes are nanoscale extracellular vesicles released by cells and studied for their role in intercellular communication, disease signaling, immune modulation, and biomarker transport. Their cargo, including proteins, lipids, DNA fragments, mRNA, microRNA, and other non-coding RNA, makes them highly relevant to liquid biopsy, oncology, neurology, cardiometabolic disease, infectious disease, and precision medicine.

The field is increasingly shaped by validated extracellular vesicle characterization standards, including guidance from the International Society for Extracellular Vesicles, and by regulatory scrutiny from agencies such as the U.S. FDA and EMA. While exosome-based therapeutics remain largely investigational, the research ecosystem is expanding through academic consortia, clinical studies, and technology innovation in isolation, purification, single-vesicle analysis, omics profiling, and scalable manufacturing.

Transformative Shifts in the Exosome Research Landscape

The exosome research landscape is being transformed by a shift from discovery science to evidence-generating translational platforms. Researchers are prioritizing reproducible isolation methods, standardized reporting, potency assays, and clinically relevant biomarker validation to address long-standing challenges around heterogeneity, sample handling, and analytical comparability. This transition is critical because extracellular vesicle populations vary by cell source, disease state, biofluid type, and purification workflow.

Another major shift is the convergence of exosome diagnostics and therapeutic engineering. In diagnostics, exosomes are being evaluated as minimally invasive biomarkers in blood, urine, saliva, cerebrospinal fluid, and other biofluids. In therapeutics, engineered exosomes are being explored as delivery vehicles for RNA, proteins, small molecules, and gene-editing components, supported by their biological compatibility and tissue-targeting potential. However, industry progress depends on rigorous quality control, GMP-compatible manufacturing, and regulatory-grade evidence.

Cumulative Impact of Artificial Intelligence on Exosome Research

Artificial intelligence is compounding the value of exosome research by improving signal detection across complex extracellular vesicle datasets. Machine learning models can help classify vesicle subpopulations, interpret proteomic and transcriptomic signatures, detect disease-associated patterns, and integrate multi-omics data from liquid biopsy workflows. AI-enabled image analysis and spectral interpretation are also strengthening nanoparticle tracking analysis, flow cytometry, electron microscopy, Raman spectroscopy, and other characterization methods.

The cumulative impact of AI is most visible where data volume, biological variability, and clinical decision thresholds intersect. AI can accelerate biomarker discovery, support patient stratification, optimize exosome loading and engineering strategies, and improve process analytics in manufacturing. To remain credible, AI deployment must use well-annotated datasets, transparent validation, bias control, and clinically meaningful endpoints, particularly as exosome diagnostics and therapeutics move closer to regulated use.

Key Regional Insights Across Global Exosome Research

Asia-Pacific is emerging as a major center for exosome research, supported by strong biomedical investment in China, Japan, South Korea, India, Australia, and ASEAN economies. The region benefits from expanding genomics infrastructure, rising oncology and chronic disease research, and government-backed biotechnology programs. North America remains a leading hub due to NIH-funded extracellular vesicle science, advanced clinical trial networks, venture investment, and a mature ecosystem for liquid biopsy, biologics manufacturing, and academic-industry collaboration.

Europe continues to advance exosome research through strong translational medicine programs, EMA-aligned regulatory pathways, and cross-border scientific networks within the European Union. Latin America is building capability through oncology, infectious disease, and academic biomedical research, with Brazil and Mexico acting as important anchors. The Middle East is investing in precision medicine, genomics, and advanced healthcare infrastructure, particularly in GCC markets. Africa offers long-term opportunity in infectious disease, maternal health, and decentralized diagnostics, although broader adoption depends on laboratory capacity, funding access, and regional biobanking infrastructure.

Key Group Insights for Exosome Research Ecosystems

ASEAN is strengthening its role in exosome research through expanding biomedical hubs in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, with opportunities in cancer diagnostics, regenerative medicine, and infectious disease research. The GCC is positioning exosome-related innovation within broader precision medicine and healthcare modernization strategies, supported by investments in genomics, specialty hospitals, and research universities. The European Union provides a coordinated environment for extracellular vesicle science through collaborative funding, clinical research networks, and harmonized regulatory expectations for advanced therapies and in vitro diagnostics.

BRICS countries are important to future exosome research scale because they combine large patient populations, growing biotechnology capacity, and increasing public investment in life sciences. G7 markets remain central to high-impact publications, regulatory science, intellectual property creation, and commercialization of exosome platforms. NATO member countries, many of which overlap with G7 and EU economies, also contribute through advanced biomedical infrastructure, defense-related biosensing research, and resilient supply chain initiatives for critical biotechnologies.

Key Country Insights Shaping Exosome Research

The United States leads in exosome research commercialization through NIH-supported science, FDA-regulated clinical development, venture-backed biotechnology, and strong university spinout activity, while Canada contributes through cell therapy, oncology, and extracellular vesicle research networks. Mexico and Brazil are expanding capabilities in clinical research, oncology, and academic bioscience, with Brazil serving as a major Latin American research base. In Europe, the United Kingdom, Germany, France, Italy, and Spain are active in extracellular vesicle biology, diagnostics, and translational medicine, while Russia maintains research interest in nanomedicine, molecular biology, and regenerative applications.

China is rapidly scaling exosome research through major investments in biotechnology, diagnostics, and biomanufacturing. India is advancing through cost-efficient biomedical research, growing genomics capacity, and rising interest in liquid biopsy. Japan and South Korea bring strengths in precision instrumentation, regenerative medicine, cell therapy, and high-quality manufacturing. Australia supports exosome innovation through oncology, neuroscience, and translational research programs, with strong links between universities, hospitals, and biotechnology companies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize standardization before scale. Exosome research programs need validated isolation workflows, orthogonal characterization methods, batch-to-batch comparability, and clear documentation aligned with international extracellular vesicle reporting guidelines. Organizations developing exosome diagnostics should invest early in clinical validation, biofluid-specific reference ranges, pre-analytical controls, and regulatory strategy for in vitro diagnostic pathways.

For therapeutic programs, leaders should focus on cell source selection, potency assays, cargo loading efficiency, biodistribution, immunogenicity, safety pharmacology, and GMP-compatible production. Strategic partnerships with academic EV centers, contract development and manufacturing organizations, AI analytics providers, and clinical networks can reduce execution risk. Intellectual property strategies should cover engineering methods, purification technologies, analytical assays, and therapeutic payload combinations.

Research Methodology

This executive summary is structured using evidence-based secondary research principles, including review of peer-reviewed extracellular vesicle literature, regulatory communications, clinical trial trends, international guidance, and publicly available institutional information from recognized scientific and health authorities. Emphasis is placed on verifiable themes rather than unsupported market claims, including standardization, translational validation, AI-enabled analytics, and regional research capacity.

The methodology applies cross-comparison across regions, economic groups, and priority countries to identify where exosome research infrastructure, clinical translation, regulatory maturity, and commercialization potential are strongest. Insights are synthesized for relevance across core industry terms such as exosome research, extracellular vesicles, liquid biopsy, exosome therapeutics, EV biomarkers, exosome isolation, and precision medicine.

Conclusion

Exosome research is entering a decisive phase in which scientific promise must be matched by reproducibility, regulatory discipline, and clinical proof. The strongest opportunities are emerging in liquid biopsy, multi-omics biomarker discovery, engineered exosome delivery, regenerative medicine, and AI-enabled extracellular vesicle analytics. Progress will depend on harmonized standards, transparent validation, and scalable manufacturing.

Organizations that combine rigorous biology, advanced analytics, high-quality clinical evidence, and regionally informed commercialization strategies will be best positioned to lead. As the field matures, exosomes are expected to remain a strategic focus in precision medicine, next-generation diagnostics, and targeted therapeutic delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Exosome Research Market, by Offering

  • 7.1. Kits & Reagents
    • 7.1.1. Isolation & Purification Kits
    • 7.1.2. Labeling & Tracking Kits
    • 7.1.3. Characterization & Quantification
    • 7.1.4. Sample Preparation & Cell Culture Reagents
  • 7.2. Instruments
    • 7.2.1. Electron Microscopes
    • 7.2.2. Flow Cytometers
    • 7.2.3. Nanoparticle Tracking Analysis (NTA)
  • 7.3. Services
    • 7.3.1. Analysis Services
    • 7.3.2. Isolation Services
    • 7.3.3. Consulting Services

8. Exosome Research Market, by Method of Isolation

  • 8.1. Immunoaffinity Capture
  • 8.2. Microfluidics-based Isolation
  • 8.3. Precipitation
  • 8.4. Size-exclusion Chromatography (SEC)
  • 8.5. Ultracentrifugation

9. Exosome Research Market, by Sample Source

  • 9.1. Blood
  • 9.2. Urine
  • 9.3. Saliva
  • 9.4. Tissue Derived

10. Exosome Research Market, by Indication

  • 10.1. Cardiology
  • 10.2. Neurology
    • 10.2.1. Alzheimer's Disease
    • 10.2.2. Multiple Sclerosis
  • 10.3. Oncology
    • 10.3.1. Breast Cancer
    • 10.3.2. Colorectal Cancer
    • 10.3.3. Lung Cancer
    • 10.3.4. Prostate Cancer

11. Exosome Research Market, by Applications

  • 11.1. Therapeutic Applications
  • 11.2. Diagnostics & Biomarker Discovery
  • 11.3. Research & Development

12. Exosome Research Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals & Clinics
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Exosome Research Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Exosome Research Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Exosome Research Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Thermo Fisher Scientific Inc.
  • 17.2. QIAGEN N.V.
  • 17.3. Bio-Techne Corporation
  • 17.4. Abcam PLC by Danaher Corporation
  • 17.5. Lonza Group AG
  • 17.6. System Biosciences, LLC by CellBio Scientific
  • 17.7. Miltenyi Biotec GmbH
  • 17.8. Takara Bio Inc.
  • 17.9. Evox Therapeutics Ltd.
  • 17.10. Capricor Therapeutics, Inc.
  • 17.11. ILIAS Biologics, Inc.
  • 17.12. ExoCoBio Inc.
  • 17.13. Aethlon Medical, Inc.
  • 17.14. Coya Therapeutics
  • 17.15. Alpha Analytical Laboratories by Pace Analytical Services
  • 17.16. BioCat GmbH by AddLife AB
  • 17.17. BioIVT, LLC
  • 17.18. Creative Biolabs
  • 17.19. Cusabio Technology LLC
  • 17.20. Diagenode Inc. by Hologic, Inc.
  • 17.21. Europa Biosite Group
  • 17.22. Fujifilm Holdings Corporation
  • 17.23. HiSS Diagnostics GmbH
  • 17.24. MBL International Corporation
  • 17.25. NanoSomiX, Inc.
  • 17.26. nRichDX Inc.
  • 17.27. Nx Pharmagen Inc.
  • 17.28. Rion,Inc.
  • 17.29. RoosterBio, Inc.
  • 17.30. Spectris plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXOSOME RESEARCH MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL EXOSOME RESEARCH MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL EXOSOME RESEARCH MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL EXOSOME RESEARCH MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXOSOME RESEARCH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL EXOSOME RESEARCH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL KITS & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL KITS & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ISOLATION & PURIFICATION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ISOLATION & PURIFICATION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ISOLATION & PURIFICATION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LABELING & TRACKING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LABELING & TRACKING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LABELING & TRACKING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CHARACTERIZATION & QUANTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CHARACTERIZATION & QUANTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CHARACTERIZATION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SAMPLE PREPARATION & CELL CULTURE REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SAMPLE PREPARATION & CELL CULTURE REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SAMPLE PREPARATION & CELL CULTURE REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELECTRON MICROSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELECTRON MICROSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELECTRON MICROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLOW CYTOMETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NANOPARTICLE TRACKING ANALYSIS (NTA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NANOPARTICLE TRACKING ANALYSIS (NTA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NANOPARTICLE TRACKING ANALYSIS (NTA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANALYSIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ISOLATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ISOLATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ISOLATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONSULTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONSULTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMMUNOAFFINITY CAPTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IMMUNOAFFINITY CAPTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMMUNOAFFINITY CAPTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MICROFLUIDICS-BASED ISOLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MICROFLUIDICS-BASED ISOLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MICROFLUIDICS-BASED ISOLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PRECIPITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PRECIPITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SIZE-EXCLUSION CHROMATOGRAPHY (SEC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SIZE-EXCLUSION CHROMATOGRAPHY (SEC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SIZE-EXCLUSION CHROMATOGRAPHY (SEC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ULTRACENTRIFUGATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ULTRACENTRIFUGATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ULTRACENTRIFUGATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TISSUE DERIVED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TISSUE DERIVED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TISSUE DERIVED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BREAST CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BREAST CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BREAST CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL COLORECTAL CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL COLORECTAL CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL COLORECTAL CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL LUNG CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL LUNG CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL LUNG CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PROSTATE CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PROSTATE CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PROSTATE CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL THERAPEUTIC APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL THERAPEUTIC APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL THERAPEUTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTICS & BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTICS & BIOMARKER DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTICS & BIOMARKER DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. GCC EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 210. GCC EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. GCC EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 214. GCC EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 216. GCC EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. GCC EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. GCC EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. G7 EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 246. G7 EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 250. G7 EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 252. G7 EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. G7 EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. G7 EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 258. NATO EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 261. NATO EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 262. NATO EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 264. NATO EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. NATO EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. NATO EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 267. NATO EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 301. MEXICO EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 329. GERMANY EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. GERMANY EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 331. GERMANY EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 332. GERMANY EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 333. GERMANY EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 334. GERMANY EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 335. GERMANY EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 336. GERMANY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 337. GERMANY EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 338. GERMANY EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 339. GERMANY EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 340. GERMANY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 341. FRANCE EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. FRANCE EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 343. FRANCE EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 344. FRANCE EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 345. FRANCE EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 346. FRANCE EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 347. FRANCE EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 348. FRANCE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 349. FRANCE EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 350. FRANCE EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 351. FRANCE EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 352. FRANCE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 353. RUSSIA EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 355. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 356. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 357. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 358. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 359. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 360. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 361. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 362. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 363. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 364. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 365. ITALY EXOSOME RESEARCH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 366. ITALY EXOSOME RESEARCH MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 367. ITALY EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 368. ITALY EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 369. ITALY EXOSOME RESEARCH MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 370. ITALY EXOSOME RESEARCH MARKET SIZE, BY METHOD OF ISOLATION, 2018-2032 (USD MILLION)
  • TABLE 371. ITALY EXOSOME RESEARCH MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 372. ITALY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 373. ITALY EXOSOME RESEARCH MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 374. ITALY EXOSOME RESEARCH MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)

TABLE 37